| Literature DB >> 25518728 |
Lei Li, Hin-chung Wong, Wenyan Nong, Man Kit Cheung, Patrick Tik Wan Law, Kai Man Kam, Hoi Shan Kwan1.
Abstract
BACKGROUND: Vibrio parahaemolyticus is a Gram-negative halophilic bacterium. Infections with the bacterium could become systemic and can be life-threatening to immunocompromised individuals. Genome sequences of a few clinical isolates of V. parahaemolyticus are currently available, but the genome dynamics across the species and virulence potential of environmental strains on a genome-scale have not been described before.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25518728 PMCID: PMC4320434 DOI: 10.1186/1471-2164-15-1135
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
List of clinical and environmental isolates analyzed in this study
| Strain | Specimen collection date | Source | tdh | trh | Serotype | CDS | Reference |
|---|---|---|---|---|---|---|---|
| VIP4-0395 | 20/11/07 | Local-Stool | + | - | O3:K6 | 4711 | This study |
| VIP4-0439 | 10/09/08 | Local-Stool | + | - | O3:K6 | 4733 | This study |
| VIP4-0445 | 26/09/08 | Local-Stool | + | - | O3:K6 | 6226 | This study |
| VIP4-0407 | 18/01/08 | Local-Stool | + | - | O3:K59 | 4692 | This study |
| AQ3810 | 1983 | Singapore | + | - | O3:K6 | 5458 | [ |
| AQ4037 | 1985 | Maldives | - | + | O3:K6 | 4447 | [ |
| RIMD2210633 | 1996 | Thailand | + | - | O3:K6 | 4831 | [ |
| Peru-466 | 1996 | Peru | + | - | O3:K6 | 4603 | [ |
| AN-5034 | 1998 | Banglandesh | + | - | O4:K68 | 4770 | [ |
| K5030 | 2005 | India | + | - | O3:K6 | 4606 | [ |
| VIP4-0430 | 03/07/08 | Local-Oyster | - | - | O4:K34 | 5698 | This study |
| VIP4-0443 | 23/09/08 | Local-Big eye fish | - | - | O2:UT | 5994 | This study |
| VIP4-0219 | 13/04/06 | Local-Salmon Sashimi | - | - | O1:UT | 4761 | This study |
| VIP4-0444 | 23/09/08 | Local-Big eye fish | - | - | O11:UT | 4976 | This study |
| VIP4-0447 | 22/10/08 | Local-Oyster | - | - | O6:UT | 5091 | This study |
UT: Untypeable.
Figure 1Neighbor-joining phylogenetic tree showing relationships among isolates inferred using SNP sites. Nodal supports were calculated from 500 bootstrap pseudoreplicates. The tree was rooted using Vibrio harveyi ATCC BAA-1116. The scale bar represents 0.002 substitutions per nucleotide position. Red color indicates clinical strains, and grey color indicates environmental strains.
Figure 2Gene repertoire analysis of (A) Pan-genome and core genome size accumulation. (B) New gene family accumulation. The green bars indicate the number of expected new gene family detected for a particular number of genomes analysed, and the orange line indicates the trend of expected new gene family with an increasing number of genomes.
Figure 3BRIG visualization of genomes. The innermost circles represent the reference sequence of V. parahaemolyticus 2210633. Outer rings illustrate shared identity with other V. parahaemolyticus isolates.
Genomic regions that found in clinical group only
| Reference No. | Chr | Start | End | Length | Features in this regions* | Descriptions |
|---|---|---|---|---|---|---|
| NC_004603.1 | Chr1 | 1630527 | 1631678 | 1151 | VP1517, VP1518 | Rhs-family protein |
| NC_004603.1 | Chr1 | 1632125 | 1632898 | 773 | VP1520, VP1521 | Hypothetical protein |
| NC_004605.1 | Chr2 | 433304 | 434859 | 1555 | VPA0442,VPA0443 | Hypothetical protein |
| NC_004605.1 | Chr2 | 436019 | 437350 | 1331 | VPA0445, VPA0446 | Methylamine utilization protein MauG precursor |
| NC_004605.1 | Chr2 | 438755 | 439983 | 1228 | VPA0447 | Hypothetical protein |
| NC_004605.1 | Chr2 | 823596 | 824400 | 804 | VPA0796 | L-allo-threonine aldolase |
| NC_004605.1 | Chr2 | 984909 | 986361 | 1452 | VPA0950, VPA0951 | Hypothetical protein |
| NC_004605.1 | Chr2 | 987912 | 990219 | 2307 | VPA0952, VPA0953(partial) | Biofilm-associated surface protein |
| NC_004605.1 | Chr2 | 994472 | 995346 | 874 | VPA0953 (partial) | Biofilm-associated surface protein |
| NC_004605.1 | Chr2 | 995407 | 998918 | 3511 | VPA0954, VPA0955, VPA0956, VPA0957 (partial) | Agglutination protein,outer membrane protein |
| NC_004605.1 | Chr2 | 998994 | 999901 | 907 | VPA0957 (partial) | Transporter binding protein |
*The gene name is based on annotation of Vibrio parahaemolyticus RIMD 2210633.
Gene clusters in small genomic island found in
| No. | Accession ID | Start | End | No. of aa* | Homolog accession no. | Description |
|---|---|---|---|---|---|---|
| 1 | AXNM01000034 | 96777 | 97262 | 162 | NP_797023.1 | SsrA-binding protein |
| 2 | AXNM01000034 | 97884 | 99086 | 401 | ZP_05776346.1 | Phage integrase family protein |
| 3 | AXNM01000034 | 99645 | 100427 | 261 | ZP_05888734.2 | Putative cyclic diguanylate phosphodiesterase (EAL) domain protein |
| 4 | AXNM01000034 | 100420 | 101163 | 248 | WP_025628220.1 | AraC family transcriptional regulator |
| 5 | AXNM01000034 | 102145 | 101300 | 282 | ZP_01990379.1 | Hypothetical protein |
| 6 | AXNM01000034 | 103426 | 104361 | 312 | ZP_01990406.1 | Hypothetical protein |
*Amino acids.
Distribution of CRISPRs in strains
| Strain | Source | CRISPR 1 | CRISPR 2 | CRISPR 3 | CRISPR 4 | CRISPR 5 | CRISPR 6 |
|---|---|---|---|---|---|---|---|
| RIMD 2210633 | Clinical | + | - | + | - | - | - |
| AQ3810 | Clinical | - | + | + | - | - | + |
| Peru 466 | Clinical | + | + | - | - | - | - |
| K5030 | Clinical | + | - | + | - | - | - |
| AQ4037 | Clinical | - | - | + | - | + | - |
| AN-5034 | Clinical | + | - | + | - | - | - |
| VIP4-0439 | Clinical | + | - | + | + | - | - |
| VIP4-0395 | Clinical | + | - | + | - | - | - |
| VIP4-0407 | Clinical | + | + | - | - | - | - |
| VIP4-0445 | Clinical | + | + | - | - | - | - |
| VIP4-0444 | Environmental | - | + | - | - | + | - |
| VIP4-0219 | Environmental | - | - | + | - | - | - |
| VIP4-0447 | Environmental | - | - | - | - | - | - |
| VIP4-0430 | Environmental | - | - | - | - | - | - |
| VIP4-0443 | Environmental | - | - | - | - | - | - |
Figure 4Subsystem annotation of The y-axis represents subsystems annotated in the RAST server whereas the x-axis shows the respective -log(P) values. P-values were calculated to examine if there is significant difference in the numbers between the subsystems of environmental strains and clinical strains. The subsystem “metabolism of aromatic compounds” was shown to have a most significant P-value (P-value <0.05, −logP >1.3).
Detection of biphenyl degradation pathway genes
| Strains* | Source | BphE1 | BphC | Bphj2 |
|---|---|---|---|---|
| VIP4-0444 | Environmental | + | + | + |
| VIP4-0219 | Environmental | + | + | + |
| VIP4-0430 | Environmental | + | + | + |
| VIP4-0443 | Environmental | + | + | + |
| VIP4-0447 | Environmental | + | + | + |
| AQ3810 | Clinical | + | + | + |
*Only strains with positive results are shown here.
Distribution of prophages in strains
| Strains* | Source | Prophage 1 (f237) | Prophage 2 (f237-like) | Prophage 3 | Prophage 4 | Prophage 5 | Prophage 6 | Prophage 7 | Prophage 8 |
|---|---|---|---|---|---|---|---|---|---|
| RIMD 2210633 | Clinical | + | |||||||
| Peru 466 | Clinical | + | |||||||
| K5030 | Clinical | + | |||||||
| AN-5034 | Clinical | + | |||||||
| VIP4-0439 | Clinical | + | |||||||
| VIP4-0395 | Clinical | + | |||||||
| VIP4-0407 | Clinical | + | |||||||
| VIP4-0445 | Clinical | + | |||||||
| AQ4037 | Clinical | - | + | ||||||
| VIP4-0444 | Environmental | - | 19312/19312 | 8265/8265 | |||||
| VIP4-0447 | Environmental | - | 12018/19312 | 6500/8265 | 91629/91629 | ||||
| VIP4-0219 | Environmental | - | 34088/34088 | ||||||
| VIP4-0430 | Environmental | - | 58355/58355 | 48569/48569 |
*VIP4-0443,AQ3810 was excluded because no prophage was found in this strain. Numbers denote the length of homolog sequences / the length of intact prophage.
Base variations in the sequence of selected strains
| Strains | Sources | Position at the | ||||||
|---|---|---|---|---|---|---|---|---|
| 576 | 900 | 1002 | 1196 | 1214 | 1244 | 1463 | ||
| RIMD 2210633 | Clinical | A | A | T | T | T | A | T |
| Peru 466 | Clinical | A | A | T | T | T | A | T |
| K5030 | Clinical | A | A | T | T | T | A | T |
| AN-5034 | Clinical | A | A | T | T | T | A | T |
| VIP4-0439 | Clinical | A | A | T | T | T | A | T |
| VIP4-0395 | Clinical | A | A | T | T | T | A | T |
| VIP4-0407 | Clinical | A | A | T | T | T | A | T |
| VIP4-0445 | Clinical | A | A | T | T | T | A | T |
| AQ4037 | Clinical | G | G | C | C | A | G | A |
| AQ3810 | Clinical | G | G | C | C | A | G | A |
| VIP4-0444 | Environmental | G | G | C | C | A | G | A |
| VIP4-0447 | Environmental | G | G | C | C | A | G | A |
| VIP4-0219 | Environmental | G | G | C | C | A | G | A |
| VIP4-0430 | Environmental | G | G | C | C | A | G | A |
| VIP4-0443 | Environmental | A | A | T | T | T | A | T |
Figure 5Architecture of the Ensembl-based genome database for